4.0 Article

Establishment of 6 pediatric rhabdomyosarcoma patient's derived xenograft models closely recapitulating patients' tumor characteristics

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine

Maria Rivera et al.

Summary: This study established, characterized, and tested therapy for colorectal carcinoma-derived PDX, revealing the responsiveness of PDX to various drugs and the molecular mechanisms underlying drug sensitivity. The correlation analysis of predictive factors for cetuximab sensitivity highlighted potential novel therapeutic targets for cancer treatment.

NEOPLASIA (2021)

Correction Genetics & Heredity

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts (vol 53, pg 86, 2021)

Xing Yi Woo et al.

Summary: A correction has been published for this paper.

NATURE GENETICS (2021)

Article Pathology

Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas

Helena Castillo-Ecija et al.

Summary: The study aimed to identify factors favoring patient-derived xenograft (PDX) engraftment and study its association with prognosis in pediatric sarcoma patients. Results showed that PDX engraftment predicted worse outcomes in newly diagnosed pediatric sarcoma patients.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2021)

Article Oncology

Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia

Anthony M. Hunter et al.

Summary: The study demonstrated that ruxolitinib showed clinical efficacy in patients with CMML, and PDX modeling can replicate patient responses seen in clinical trials.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium

Jack F. Shern et al.

Summary: This study is the largest genomic characterization of clinically annotated rhabdomyosarcoma tumors to date, providing prognostic genetic features that refine risk stratification and will be incorporated into prospective trials.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Oncology

Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer

Giulia Rizzo et al.

Summary: Patient-derived models are innovative and valuable pre-clinical tools for studying the progression and metastasis of CRC, developing novel therapeutic strategies, creating a drug screening platform, and predicting the efficacy of clinical response to therapy.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Genetics & Heredity

Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models

Deepak Vangala et al.

Summary: By testing in vivo selection of anti-EGFR SR tumors in CRC PDX models, researchers have revealed the molecular details of developing secondary resistance mechanisms in CRC, suggesting that anti-EGFR tolerant cells via transcriptional reprogramming may be a common cause. Successful treatment of secondary resistant xenograft tumors was achieved using tailored targeted therapies.

GENOME MEDICINE (2021)

Article Oncology

Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer

Santosh Renuse et al.

Summary: Pancreatic cancer, especially pancreatic ductal adenocarcinoma, is a deadly malignancy with poor response to traditional chemotherapies. Protein tyrosine kinases are commonly hyperactivated in cancers, making them potential therapeutic targets. The use of patient-derived tumor xenografts (PDXs) in animal models, such as mice, can help identify hyperactivated kinases for targeted therapies.

CANCERS (2021)

Editorial Material Oncology

A home run for rhabdomyosarcoma after 30 years: What now?

Andrea Ferrari et al.

TUMORI JOURNAL (2020)

Article Biochemistry & Molecular Biology

PDX Finder: A portal for patient-derived tumor xenograft model discovery

Nathalie Conte et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Multidisciplinary Sciences

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness

Moro Massimo et al.

SCIENTIFIC REPORTS (2017)

Review Oncology

The biology and function of fibroblasts in cancer

Raghu Kalluri

NATURE REVIEWS CANCER (2016)

Article Oncology

Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma

Xiang Chen et al.

CANCER CELL (2013)

Review Biochemistry & Molecular Biology

Microenvironmental regulation of tumor progression and metastasis

Daniela F. Quail et al.

NATURE MEDICINE (2013)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Oncology

Guidelines for the welfare and use of animals in cancer research

P. Workman et al.

BRITISH JOURNAL OF CANCER (2010)